N.N. Blokhin National Medical Research Center of Oncology Trials

N.N. Blokhin National Medical Research Center of Oncology	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tjulandin, Sergei A

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Palbociclib, Ibrance, Ribociclib, Kisqali, Abemaciclib, VERZENIO, Letrozole, Anastrozole, Tamoxifen, Fulvestrant, Faslodex, Exemestane, Exemestane will be dosed daily at a fixed dose of 25mg/day throughout the study., Alpelisib, PIQRAY

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Matveev, Vsevolod B

NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting

496

Europe, US, RoW

Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone

Jiangsu HengRui Medicine Co., Ltd.

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

12/26

i-RECORd, NCT05363657: International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Recruiting

N/A

10000

Europe, Japan, US, RoW

Partial Nephrectomy (PN), Radical Nephrectomy (RN), Ablation therapy (AT), Active Surveillance (AS)

Azienda Ospedaliero-Universitaria Careggi, Società Italiana di Urologia (SIU), Italian Group for Advanced Laparo-Endoscopic and Robotic Urologic Surgery (AGILE)

Kidney Cancer

12/23

12/28

Stenina, Marina

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Kononets, Pavel

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27

NCT05057143: 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Recruiting

N/A

RoW

Implants, Plates

Blokhin's Russian Cancer Research Center

Tumor of Bone, Chest Wall Tumor, Chest Wall Sarcoma, Sarcoma of Bone, Surgery, Implant Site Reaction

12/25

Zhukova, Ludmila G

FERMATA, NCT03912415 / 2019-000623-40: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer

Recruiting

316

RoW

BCD-100, Bevacizumab, Paclitaxel, Cisplatin (or Carboplatin), Placebo

Biocad

Cervical Cancer

12/24

OBERTON, NCT03913923: Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

Active, not recruiting

117

RoW

BCD-217, BCD-100, Placebo

Biocad

Melanoma, Melanoma Metastatic

07/23

12/23

NCT05551767: Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Recruiting

120

RoW

Pembrolizumab, cisplatin and 5-FU

City Clinical Oncology Hospital No 1, Moscow City Oncology Hospital No. 62, Moscow Clinical Scientific Center

Neck Cancer

12/23

12/24

NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Completed

RoW

Stimotimagene copolymerplasmid, AntioncoRAN-M, Ganciclovir, Cymeven®

Gene Surgery LLC

Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms

04/24

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Orlova, Kristina V

UNIVERSE, NCT06640530: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin

Recruiting

392

RoW

BCD-263, Nivolumab, Opdivo

Biocad

Advanced Melanoma, Melanoma (Skin)

12/25

03/27

NCT06112808: A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

Recruiting

300

RoW

BCD-263, Nivolumab, Opdivo

Biocad

Advanced Melanoma

09/24

01/27

MoleMed, NCT04353050: Atypical MOLes and Melanoma Early Detection Study

Recruiting

N/A

350

RoW

Non-invasive adhesive system (patch)

Russian Academy of Medical Sciences, Blokhin's Russian Cancer Research Center

Melanoma, Melanoma (Skin), Moles, Nevus, Nevus, Blue, Nevus, Pigmented, Nevus, Spitz, Nevi, Spindle Cell, Nevi, Dysplastic, Dysplastic Nevus Syndrome, Mucosal Melanoma, Mucosal Melanosis

01/23

11/23

FORA, NCT05120024: Multicenter Study of Safety and Efficacy of Prolgolimab in Patients With Advanced Melanoma in Routine Clinical Practice

Recruiting

N/A

350

RoW

MelanomaPRO, Russia

Advanced Melanoma

12/22

12/23

Abouhaidar, Omar

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27

Akhmedov, Parvin

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tjulandin, Sergei A

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Matveev, Vsevolod B

Active, not recruiting

496

Europe, US, RoW

Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone

Jiangsu HengRui Medicine Co., Ltd.

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

12/26

i-RECORd, NCT05363657: International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Recruiting

N/A

10000

Europe, Japan, US, RoW

Partial Nephrectomy (PN), Radical Nephrectomy (RN), Ablation therapy (AT), Active Surveillance (AS)

Azienda Ospedaliero-Universitaria Careggi, Società Italiana di Urologia (SIU), Italian Group for Advanced Laparo-Endoscopic and Robotic Urologic Surgery (AGILE)

Kidney Cancer

12/23

12/28

Stenina, Marina

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Kononets, Pavel

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27

NCT05057143: 3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Recruiting

N/A

RoW

Implants, Plates

Blokhin's Russian Cancer Research Center

Tumor of Bone, Chest Wall Tumor, Chest Wall Sarcoma, Sarcoma of Bone, Surgery, Implant Site Reaction

12/25

Zhukova, Ludmila G

Recruiting

316

RoW

BCD-100, Bevacizumab, Paclitaxel, Cisplatin (or Carboplatin), Placebo

Biocad

Cervical Cancer

12/24

Active, not recruiting

117

RoW

BCD-217, BCD-100, Placebo

Biocad

Melanoma, Melanoma Metastatic

07/23

12/23

NCT05551767: Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Recruiting

120

RoW

Pembrolizumab, cisplatin and 5-FU

City Clinical Oncology Hospital No 1, Moscow City Oncology Hospital No. 62, Moscow Clinical Scientific Center

Neck Cancer

12/23

12/24

NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Completed

RoW

Stimotimagene copolymerplasmid, AntioncoRAN-M, Ganciclovir, Cymeven®

Gene Surgery LLC

Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms

04/24

NCT04852081: Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Recruiting

N/A

1000

RoW

Blokhin's Russian Cancer Research Center

Breast Cancer Stage IV

12/21

Orlova, Kristina V

UNIVERSE, NCT06640530: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin

Recruiting

392

RoW

BCD-263, Nivolumab, Opdivo

Biocad

Advanced Melanoma, Melanoma (Skin)

12/25

03/27

NCT06112808: A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

Recruiting

300

RoW

BCD-263, Nivolumab, Opdivo

Biocad

Advanced Melanoma

09/24

01/27

MoleMed, NCT04353050: Atypical MOLes and Melanoma Early Detection Study

Recruiting

N/A

350

RoW

Non-invasive adhesive system (patch)

Russian Academy of Medical Sciences, Blokhin's Russian Cancer Research Center

Melanoma, Melanoma (Skin), Moles, Nevus, Nevus, Blue, Nevus, Pigmented, Nevus, Spitz, Nevi, Spindle Cell, Nevi, Dysplastic, Dysplastic Nevus Syndrome, Mucosal Melanoma, Mucosal Melanosis

01/23

11/23

FORA, NCT05120024: Multicenter Study of Safety and Efficacy of Prolgolimab in Patients With Advanced Melanoma in Routine Clinical Practice

Recruiting

N/A

350

RoW

MelanomaPRO, Russia

Advanced Melanoma

12/22

12/23

Abouhaidar, Omar

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27

Akhmedov, Parvin

NCT05547529: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Recruiting

156

RoW

Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy., Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

Blokhin's Russian Cancer Research Center

Esophageal Cancer

09/25

09/27



	Diseases Companies Products Productz Mechanisms of Action Sites